Letters Breakthrough cancer pain

Morphine remains gold standard in breakthrough cancer pain

BMJ 2008; 337 doi: http://dx.doi.org/10.1136/bmj.a3104 (Published 24 December 2008) Cite this as: BMJ 2008;337:a3104
  1. Vicente Ruiz-Garcia1,
  2. Eduardo Lopez-Briz1
  1. 1Home Hospitalisation Unit, HU La Fe, 46014 Valencia, Spain
  1. ruiz_vicgar{at}redcaspe.org

    Although Davies and colleagues argue that little evidence supports the unlicensed use of oral morphine,1 morphine remains the gold standard in cancer pain. Licensed or unlicensed use is a transient status, especially in palliative care. Little evidence may support the use of oral …

    Sign in

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe